Skip to main content
. Author manuscript; available in PMC: 2021 Sep 20.
Published in final edited form as: Immunohorizons. 2021 Jun 17;5(6):466–476. doi: 10.4049/immunohorizons.2100022

Table 3.

Median (IQR) IgG levels, fold RBD-ACE2 inhibition, and SARS-CoV-2 neutralization titers five weeks after resolution of COVID-19 symptoms according to clinical symptoms in non-hospitalized subjects

N Anti-Spike a Anti-NTD a Anti-RBD a Anti-N a ACE-2 Inhib. Neut. Titer

All subjects 94 19 (7.0, 35) 0.27 (0.10, 0.69) 5.1 (1.8, 12) 31 (11, 51) 73 (20, 287) 20 (10, 40)
Fever 59 29 (7.9, 39) ** 0.41 (0.17, 0.86) ** 9.2 (2.8, 14) ** 40 (23, 54) * 121 (37, 328) ** 20 (10, 80) ***
Chills b 59 21 (7.9, 39) 0.32 (0.14, 0.82) 5.9 (2.1, 14) 38 (16, 53) 73 (34, 305) 20 (10, 80) *
Productive cough 37 26 (10, 38) 0.44 (0.18, 0.74) * 8.7 (3.2, 13) * 42 (23, 55) 131 (42, 305) * 20 (10, 80) **
Dry cough 58 26 (10, 38) ** 0.32 (0.17, 0.73) * 7.4 (2.8, 13) ** 39 (21, 53) 124 (37, 298) * 20 (10, 40) *
Shortness of breath 47 26 (6.7, 38) 0.27 (0.12, 0.74) 5.9 (1.8, 13) 27 (11, 56) 85 (22, 305) 20 (10, 80)
Chest tightness 60 21 (7.2, 35) 0.26 (0.09, 0.71) 5.8 (1.8, 13) 36 (12, 56) 79 (21, 287) 20 (10, 40)
Sore throat 45 22 (8.4, 35) 0.34 (0.17, 0.68) 6.9 (2.4, 12) 38 (14, 53) 73 (20, 298) 20 (10, 40)
Loss of taste or smell 58 21 (8.0, 36) 0.33 (0.10, 0.73) 5.0 (1.8, 13) 31 (14, 54) 73 (22, 298) 20 (10, 40)
Runny or stuffed nose 54 20 (6.7, 37) 0.28 (0.09, 0.69) 5.5 (1.7, 12) 35 (16, 53) 73 (20, 279) 20 (10, 40)
Body aches 69 24 (8.4, 39) ** 0.29 (0.14, 0.86) * 6.9 (2.2, 14) ** 38 (16, 53) 93 (28, 298) * 20 (10, 80) *
Headaches 68 24 (9.1, 35) * 0.31 (0.16, 0.71) * 6.8 (2.9, 13) ** 36 (18, 53) 92 (26, 293) 20 (10, 40) *
Low appetite 59 27 (9.8, 43) *** 0.41 (0.18, 1.0) *** 8.7 (2.9, 16) *** 40 (22, 56) ** 123 (28, 311) ** 20 (10, 80) ***
Nausea 32 29 (9.2, 46) * 0.45 (0.26, 1.1) ** 9.1 (3.5, 14) * 42 (26, 56) * 95 (19, 332) 20 (10, 80)
Vomiting 13 30 (20, 43) * 0.93 (0.44, 1.1) *** 10 (4.8, 20) * 48 (42, 82) ** 131 (26, 376) 40 (10, 80)
Abdominal pain 17 35 (17, 47) * 1.0 (0.28, 1.6) ** 14 (5.6, 20) * 48 (29, 69) * 310 (47, 756) * 80 (20, 80) **
Diarrhea 42 28 (13, 43) ** 0.44 (0.23, 0.93) ** 8.9 (4.1, 14) * 41 (23, 82) ** 124 (47, 392) ** 30 (10, 80) *
a

Values are x105

b

Data missing for three subjects

*

p<0.05

**

p<0.01

***

p<0.001